This phenomenon is generally seen in adult obesity, which is hypertrophic in nature and the reason why PPARγ agonists such as thiazolidinediones (TZDs) are useful in treating obesity (Choe et al., 2016). This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.